Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation

The Journal of Experimental Medicine
Almut Meyer-BahlburgDavid J Rawlings

Abstract

We have characterized a distinct, late transitional B cell subset, CD21(int) transitional 2 (T2) B cells. In contrast to early transitional B cells, CD21(int) T2 B cells exhibit augmented responses to a range of potential microenvironmental stimuli. Adoptive transfer studies demonstrate that this subset is an immediate precursor of both follicular mature and marginal zone (MZ) B cells. In vivo, a large percentage of CD21(int) T2 B cells has entered the cell cycle, and the cycling subpopulation exhibits further augmentation in mitogenic responses and B cell-activating factor of the TNF family (BAFF) receptor expression. Consistent with these features, CD21(int) T2 cells exhibit preferential responses to BAFF-facilitated homeostatic signals in vivo. In addition, we demonstrate that M167 B cell receptor (BCR) idiotypic-specific B cells are first selected within the cycling CD21(int) T2 population, ultimately leading to preferential enrichment of these cells within the MZ B cell compartment. These data, in association with the coordinate role for BAFF and microenvironmental cues in determining the mature BCR repertoire, imply that this subset functions as a unique selection point in peripheral B cell development.

References

Jun 1, 1991·The Journal of Experimental Medicine·H GuI Förster
Nov 28, 1991·Nature·D M RussellD Nemazee
Jun 1, 1995·The Journal of Experimental Medicine·R CarsettiM C Lamers
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·C C Goodnow
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·M H LevineM J Shlomchik
Oct 18, 2000·The Journal of Experimental Medicine·A CariappaS Pillai
Mar 13, 2001·Annual Review of Immunology·R R Hardy, K Hayakawa
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D AllmanR R Hardy
Jan 10, 2002·The Journal of Clinical Investigation·Joanna GroomFabienne Mackay
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas T Su, David J Rawlings
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Benjamin L HsuMichael P Cancro
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark S CabatinganRobert T Woodland
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susan Harless Smith, Michael P Cancro
Jun 18, 2003·Trends in Immunology·James B ChungJohn G Monroe
Aug 16, 2003·Science·Hedda WardemannMichel C Nussenzweig
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongsheng Wang, Stephen H Clarke
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonid GorelikSusan L Kalled
Feb 14, 2004·Immunological Reviews·Shiv PillaiStewart T Moran
Mar 17, 2004·The Journal of Experimental Medicine·Emmanuelle GaudinAntónio A Freitas
Jun 10, 2004·Arthritis and Rheumatism·Weimin LiuRobert H Carter
Dec 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Xiangao HuangSelina Chen-Kiang
Mar 2, 2005·The Journal of Experimental Medicine·Sergey YurasovMichel C Nussenzweig
Mar 18, 2005·Annual Review of Immunology·Shiv PillaiStewart T Moran
Apr 14, 2005·Seminars in Immunology·Robert T Woodland, Madelyn R Schmidt
May 18, 2005·The Journal of Experimental Medicine·Jonathan SamuelsEric Meffre
Nov 1, 2005·European Journal of Immunology·Stefan Wirths, Antonio Lanzavecchia
Nov 2, 2005·The Journal of Experimental Medicine·Bhaskar SrivastavaDavid Allman
Dec 14, 2005·Annals of the Rheumatic Diseases·Y ShoenfeldP-L Meroni
Jul 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Colleen M DoyleEline T Luning Prak
Aug 19, 2006·Seminars in Immunology·Robert Brink
Aug 26, 2006·Seminars in Immunology·Robert T WoodlandCraig B Thompson
Oct 13, 2006·Blood·H Franklin Bunn

❮ Previous
Next ❯

Citations

Apr 9, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Yantang WangGuixiu Shi
Apr 10, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Moncef Zouali, Eugene A Uy
Jun 13, 2009·Nature Reviews. Immunology·Fabienne Mackay, Pascal Schneider
Aug 26, 2009·Nature Reviews. Immunology·Michael P Cancro
Dec 29, 2010·Proceedings of the National Academy of Sciences of the United States of America·Geoffrey T HartStephen C Jameson
Mar 24, 2010·The Journal of Experimental Medicine·Robert B HendersonVictor L J Tybulewicz
Jun 16, 2010·The Journal of Experimental Medicine·Jolan E WalterLuigi D Notarangelo
Jun 16, 2010·The Journal of Experimental Medicine·Barbara CassaniAnna Villa
Aug 31, 2011·The Journal of Experimental Medicine·Shirly Becker-HermanDavid J Rawlings
Dec 26, 2012·The Journal of Experimental Medicine·Sarah F AndrewsPatrick C Wilson
May 21, 2013·Rheumatology·Ikuko Ueda-HayakawaHiroyuki Okamoto
Apr 27, 2013·The Journal of Clinical Investigation·Xuezhi DaiDavid J Rawlings
May 11, 2010·PLoS Neglected Tropical Diseases·Daniela A BermejoAdriana Gruppi
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Almut Meyer-Bahlburg, David J Rawlings
Sep 12, 2008·Genes and Immunity·I DebnathJ H Weis
Jul 4, 2012·Journal of Autoimmunity·Ayan LahiriJacques-Olivier Pers
Sep 3, 2010·Journal of Autoimmunity·Ruby AlonsoYves Renaudineau
Sep 6, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Adam KlocperkAnna Šedivá
Nov 26, 2015·Current Opinion in Immunology·Genita MetzlerDavid J Rawlings
Jan 17, 2009·The Journal of Investigative Dermatology·Nataly Manjarrez-OrduñoIñaki Sanz
Jan 17, 2009·The Journal of Investigative Dermatology·Derek CainGarnett Kelsoe
Sep 17, 2008·European Journal of Pharmacology·Jian SunBeifen Shen
Dec 3, 2013·Immunologic Research·Wasif N KhanEmily S Clark
Jun 19, 2008·Cytometry. Part B, Clinical Cytometry·Klaus Warnatz, Michael Schlesier
Feb 14, 2009·The EMBO Journal·Christian SchmidtPhilip W Tucker
Oct 25, 2011·Immunological Reviews·Robert C RickertAna V Miletic
Aug 24, 2010·Immunological Reviews·Fabienne MackayMargaret L Hibbs
Mar 17, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N K Tchao, L A Turka
Feb 9, 2012·European Journal of Immunology·Sarah F AndrewsDavid J Rawlings
Sep 25, 2010·European Journal of Immunology·Doris Peckl-SchmidGernot Achatz
Sep 16, 2015·The Journal of Experimental Medicine·Nikita S KolhatkarDavid J Rawlings
Jun 2, 2015·Immunity, Inflammation and Disease·Joseph J DolenceKay L Medina
Mar 21, 2015·The Journal of Allergy and Clinical Immunology·Maria Carmina CastielloMarita Bosticardo
Jan 27, 2015·The Journal of Nutritional Biochemistry·Eric A GurzellJenifer I Fenton
Nov 19, 2013·Cell Reports·Julia JellusovaRobert C Rickert
May 15, 2013·The American Journal of Pathology·Dai MiyazakiYoshitsugu Inoue

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
flow cytometry
PCR
FACS
FCS

Software Mentioned

FACSDiva
FlowJo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.